Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

Emerging markets push has CRO at ready

Wednesday, December 2nd, 2009

A common theme echoed by big pharma these days, particularly during the recent blitz of third-quarter earnings releases, is a renewed focus on emerging markets. (Sanofi-Aventis and GlaxoSmithKline are two notable examples). Of course, the importance of tapping emerging markets – both for drug research and commercial medicines – has ...

   
©2012 UBM Canon